Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Chronic Obstructive Lung Disease | Research article

The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis

Authors: Tao Yang, Chihua Chen, Zhongyuanlong Chen

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

It is necessary to analyze the CT pulmonary vascular parameters and disease severity in chronic obstructive pulmonary disease (COPD) patients to provide evidence support for the management of COPD.

Methods

COPD patients on acute exacerbation admitted to our hospital from COPD patients from January 2019 to March 2020 was selected. The characteristics and ratio of the cross-sectional area (CSA) of small pulmonary vessels to the total area of the lung field, and the ratio of pulmonary artery and aorta (PA/A) cross-sectional diameter in patients with COPD were analyzed.

Results

A total of 128 COPD patients were included. There were significant differences in the duration of COPD, smoking history, the PaO2, PaCO2, pH, and FEV1, FVC and FEV1/FVC among COPD patients with different severity (all p < 0.05). The duration of COPD, smoking, PaO2, PaCO2, CSA and PA/A were correlated with the COPD severity (all p < 0.05). Both CSA, PA/A were correlated with post BD FEV1 (all p < 0.05). The cutoff value of CSA and PA/A for the diagnosis of severe COPD was 0.61 and 0.87 respectively, and the AUC of CSA and PA/A for the diagnosis of severe COPD was 0.724 and 0.782 respectively.

Conclusions

Patients with CSA ≤ 0.61 and PA/A ≥ 0.87 may have higher risks for severe COPD, and more studies are needed in the future to further elucidate the management of COPD.
Literature
1.
go back to reference Hillas G, Papaporfyriou A, Dimakou K, Papaioannou AI. Pharmacological treatment of stable COPD: need for a simplified approach. Postgrad Med. 2020;132(2):126–31.PubMedCrossRef Hillas G, Papaporfyriou A, Dimakou K, Papaioannou AI. Pharmacological treatment of stable COPD: need for a simplified approach. Postgrad Med. 2020;132(2):126–31.PubMedCrossRef
3.
go back to reference Wu Y, Guan S, Ge Y, Yang Y, Cao Y, Zhou J. Cigarette smoke promotes chronic obstructive pulmonary disease (COPD) through the miR-130a/Wnt1 axis. Toxicol In Vitro. 2020;65:104770.PubMedCrossRef Wu Y, Guan S, Ge Y, Yang Y, Cao Y, Zhou J. Cigarette smoke promotes chronic obstructive pulmonary disease (COPD) through the miR-130a/Wnt1 axis. Toxicol In Vitro. 2020;65:104770.PubMedCrossRef
4.
go back to reference Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786–97.PubMedCrossRef Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786–97.PubMedCrossRef
5.
go back to reference Guder G, Stork S. COPD and heart failure: differential diagnosis and comorbidity. Herz. 2019;44(6):502–8.PubMedCrossRef Guder G, Stork S. COPD and heart failure: differential diagnosis and comorbidity. Herz. 2019;44(6):502–8.PubMedCrossRef
6.
go back to reference Ruppel GL, Enright PL. Pulmonary function testing. Respir Care. 2012;57(1):165–75.PubMed Ruppel GL, Enright PL. Pulmonary function testing. Respir Care. 2012;57(1):165–75.PubMed
7.
go back to reference Crimi C, Heffler E, Augelletti T, Campisi R, Noto A, Vancheri C, Crimi N. Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3131–9.PubMedPubMedCentralCrossRef Crimi C, Heffler E, Augelletti T, Campisi R, Noto A, Vancheri C, Crimi N. Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3131–9.PubMedPubMedCentralCrossRef
8.
go back to reference Skjorten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S. Exercise capacity in COPD patients with exercise-induced pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2018;13:3599–610.PubMedPubMedCentralCrossRef Skjorten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S. Exercise capacity in COPD patients with exercise-induced pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2018;13:3599–610.PubMedPubMedCentralCrossRef
9.
go back to reference Marklund S, Bui KL, Nyberg A. Measuring and monitoring skeletal muscle function in COPD: current perspectives. Int J Chron Obstruct Pulmon Dis. 2019;14:1825–38.PubMedPubMedCentralCrossRef Marklund S, Bui KL, Nyberg A. Measuring and monitoring skeletal muscle function in COPD: current perspectives. Int J Chron Obstruct Pulmon Dis. 2019;14:1825–38.PubMedPubMedCentralCrossRef
10.
go back to reference Pereira de Araujo CL, Pereira Reinaldo G, Foscarini BG, Ferreira Schneider B, Moraes Menezes VJ, Dal Lago P. The effects of pulmonary rehabilitation on endothelial function and arterial stiffness in patients with chronic obstructive pulmonary disease. Physiother Res Int. 2020;25(2):e1820.PubMedCrossRef Pereira de Araujo CL, Pereira Reinaldo G, Foscarini BG, Ferreira Schneider B, Moraes Menezes VJ, Dal Lago P. The effects of pulmonary rehabilitation on endothelial function and arterial stiffness in patients with chronic obstructive pulmonary disease. Physiother Res Int. 2020;25(2):e1820.PubMedCrossRef
11.
go back to reference Coste F, Dournes G, Dromer C, Blanchard E, Freund-Michel V, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, et al. CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension. Thorax. 2016;71(9):830–7.PubMedCrossRef Coste F, Dournes G, Dromer C, Blanchard E, Freund-Michel V, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, et al. CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension. Thorax. 2016;71(9):830–7.PubMedCrossRef
12.
go back to reference Rahman O, Markl M, Balte P, Berhane H, Blanken C, Suwa K, Dashnaw S, Wieben O, Bluemke DA, Prince MR, et al. Reproducibility and changes in vena caval blood flow by using 4D flow MRI in pulmonary emphysema and chronic obstructive pulmonary disease (COPD): the multi-ethnic study of atherosclerosis (MESA) COPD substudy. Radiology. 2019;292(3):585–94.PubMedCrossRef Rahman O, Markl M, Balte P, Berhane H, Blanken C, Suwa K, Dashnaw S, Wieben O, Bluemke DA, Prince MR, et al. Reproducibility and changes in vena caval blood flow by using 4D flow MRI in pulmonary emphysema and chronic obstructive pulmonary disease (COPD): the multi-ethnic study of atherosclerosis (MESA) COPD substudy. Radiology. 2019;292(3):585–94.PubMedCrossRef
13.
go back to reference Takayanagi S, Kawata N, Tada Y, Ikari J, Matsuura Y, Matsuoka S, Matsushita S, Yanagawa N, Kasahara Y, Tatsumi K. Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression? Int J Chron Obstruct Pulmon Dis. 2017;12:551–60.PubMedPubMedCentralCrossRef Takayanagi S, Kawata N, Tada Y, Ikari J, Matsuura Y, Matsuoka S, Matsushita S, Yanagawa N, Kasahara Y, Tatsumi K. Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression? Int J Chron Obstruct Pulmon Dis. 2017;12:551–60.PubMedPubMedCentralCrossRef
14.
go back to reference Balkissoon R: Journal Club-COPD2020 Update. Global initiative for chronic obstructive lung disease 2020 report and the journal of the COPD foundation special edition, moving to a new definition for COPD: "COPDGene((R)) 2019". Chronic Obstr Pulm Dis. 2019, 6(4). Balkissoon R: Journal Club-COPD2020 Update. Global initiative for chronic obstructive lung disease 2020 report and the journal of the COPD foundation special edition, moving to a new definition for COPD: "COPDGene((R)) 2019". Chronic Obstr Pulm Dis. 2019, 6(4).
15.
go back to reference Wang X, Fang X. Global Initiative for Chronic Obstructive Pulmonary Disease 2019: interpretation of the global strategy for the diagnosis, treatment and prevention of chronic obstructive pulmonary disease. Chin Gen Pract. 2019;27(18):2141–9. Wang X, Fang X. Global Initiative for Chronic Obstructive Pulmonary Disease 2019: interpretation of the global strategy for the diagnosis, treatment and prevention of chronic obstructive pulmonary disease. Chin Gen Pract. 2019;27(18):2141–9.
16.
go back to reference Ostridge K, Williams NP, Kim V, Harden S, Bourne S, Clarke SC, Aris E, Mesia-Vela S, Devaster JM, Tuck A, et al. Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res. 2018;19(1):31.PubMedPubMedCentralCrossRef Ostridge K, Williams NP, Kim V, Harden S, Bourne S, Clarke SC, Aris E, Mesia-Vela S, Devaster JM, Tuck A, et al. Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res. 2018;19(1):31.PubMedPubMedCentralCrossRef
18.
go back to reference Liao Y, Wang X, Bai Y. The clinical significance of high-resolution CT pulmonary vascular indexes in evaluating pulmonary hypertension in patients with COPD. Int J Respir. 2018;12(7):502–9. Liao Y, Wang X, Bai Y. The clinical significance of high-resolution CT pulmonary vascular indexes in evaluating pulmonary hypertension in patients with COPD. Int J Respir. 2018;12(7):502–9.
19.
go back to reference Wang C, Xu J, Wu Z. Correlation between CT pulmonary vascular parameters and severity of patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Respir. 2019;39(7):515–20. Wang C, Xu J, Wu Z. Correlation between CT pulmonary vascular parameters and severity of patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Respir. 2019;39(7):515–20.
20.
go back to reference Venkata AN. Asthma-COPD overlap: review of diagnosis and management. Curr Opin Pulm Med. 2020;26(2):155–61.PubMedCrossRef Venkata AN. Asthma-COPD overlap: review of diagnosis and management. Curr Opin Pulm Med. 2020;26(2):155–61.PubMedCrossRef
21.
go back to reference Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–60.PubMedPubMedCentralCrossRef Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–60.PubMedPubMedCentralCrossRef
22.
go back to reference Vanfleteren LE, Beghe B, Andersson A, Hansson D, Fabbri LM, Grote L. Multimorbidity in COPD, does sleep matter? Eur J Intern Med. 2020;73:7–15.PubMedCrossRef Vanfleteren LE, Beghe B, Andersson A, Hansson D, Fabbri LM, Grote L. Multimorbidity in COPD, does sleep matter? Eur J Intern Med. 2020;73:7–15.PubMedCrossRef
23.
go back to reference Vogelmeier CF, Roman-Rodriguez M, Singh D, Han MK, Rodriguez-Roisin R, Ferguson GT. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020;166:105938.PubMedCrossRef Vogelmeier CF, Roman-Rodriguez M, Singh D, Han MK, Rodriguez-Roisin R, Ferguson GT. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020;166:105938.PubMedCrossRef
24.
go back to reference Brassington K, Selemidis S, Bozinovski S, Vlahos R. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease. Clin Sci (Lond). 2019;133(7):885–904.CrossRef Brassington K, Selemidis S, Bozinovski S, Vlahos R. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease. Clin Sci (Lond). 2019;133(7):885–904.CrossRef
26.
go back to reference Laddha AP, Kulkarni YA. VEGF and FGF-2: Promising targets for the treatment of respiratory disorders. Respir Med. 2019;156:33–46.PubMedCrossRef Laddha AP, Kulkarni YA. VEGF and FGF-2: Promising targets for the treatment of respiratory disorders. Respir Med. 2019;156:33–46.PubMedCrossRef
27.
go back to reference Coste F, Benlala I, Dournes G, Dromer C, Blanchard E, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, et al. Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2019;14:381–9.PubMedPubMedCentralCrossRef Coste F, Benlala I, Dournes G, Dromer C, Blanchard E, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, et al. Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2019;14:381–9.PubMedPubMedCentralCrossRef
28.
go back to reference Yoshimura K, Suzuki Y, Uto T, Sato J, Imokawa S, Suda T. Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:1435–45.PubMedPubMedCentralCrossRef Yoshimura K, Suzuki Y, Uto T, Sato J, Imokawa S, Suda T. Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:1435–45.PubMedPubMedCentralCrossRef
29.
go back to reference Saruya S, Matsuoka S, Yamashiro T, Matsushita S, Fujikawa A, Yagihashi K, Kurihara Y, Nakajima Y. Quantitative CT measurements of small pulmonary vessels in chronic obstructive pulmonary disease: do they change on follow-up scans? Clin Physiol Funct Imaging. 2016;36(3):211–7.PubMedCrossRef Saruya S, Matsuoka S, Yamashiro T, Matsushita S, Fujikawa A, Yagihashi K, Kurihara Y, Nakajima Y. Quantitative CT measurements of small pulmonary vessels in chronic obstructive pulmonary disease: do they change on follow-up scans? Clin Physiol Funct Imaging. 2016;36(3):211–7.PubMedCrossRef
30.
go back to reference Nambu A, Zach J, Schroeder J, Jin G, Kim SS, Kim YI, Schnell C, Bowler R, Lynch DA. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease. Eur J Radiol. 2016;85(11):2144–51.PubMedPubMedCentralCrossRef Nambu A, Zach J, Schroeder J, Jin G, Kim SS, Kim YI, Schnell C, Bowler R, Lynch DA. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease. Eur J Radiol. 2016;85(11):2144–51.PubMedPubMedCentralCrossRef
31.
go back to reference Coste F, Benlala I, Dournes G, Girodet PO, Laurent F, Berger P. Assessing pulmonary hypertension in COPD. Is there a role for computed tomography? Int J Chron Obstruct Pulmon Dis. 2019;14:2065–79.PubMedPubMedCentralCrossRef Coste F, Benlala I, Dournes G, Girodet PO, Laurent F, Berger P. Assessing pulmonary hypertension in COPD. Is there a role for computed tomography? Int J Chron Obstruct Pulmon Dis. 2019;14:2065–79.PubMedPubMedCentralCrossRef
32.
go back to reference Yoshimura K, Suzuki Y, Inoue Y, Nishimoto K, Mori K, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, et al. Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease. PLoS ONE. 2018;13(6):e0198479.PubMedPubMedCentralCrossRef Yoshimura K, Suzuki Y, Inoue Y, Nishimoto K, Mori K, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, et al. Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease. PLoS ONE. 2018;13(6):e0198479.PubMedPubMedCentralCrossRef
33.
go back to reference Faight EM, Verdelis K, Zourelias L, Chong R, Benza RL, Shields KJ. MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension. Pulm Circ. 2017;7(2):522–30.PubMedPubMedCentralCrossRef Faight EM, Verdelis K, Zourelias L, Chong R, Benza RL, Shields KJ. MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension. Pulm Circ. 2017;7(2):522–30.PubMedPubMedCentralCrossRef
34.
go back to reference Brugniaux JV, Coombs GB, Barak OF, Dujic Z, Sekhon MS, Ainslie PN. Highs and lows of hyperoxia: physiological, performance, and clinical aspects. Am J Physiol Regul Integr Comp Physiol. 2018;315(1):R1–27.PubMedCrossRef Brugniaux JV, Coombs GB, Barak OF, Dujic Z, Sekhon MS, Ainslie PN. Highs and lows of hyperoxia: physiological, performance, and clinical aspects. Am J Physiol Regul Integr Comp Physiol. 2018;315(1):R1–27.PubMedCrossRef
35.
go back to reference Kovacs G, Agusti A, Barbera JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H. Pulmonary vascular involvement in chronic obstructive pulmonary disease. Is there a pulmonary vascular phenotype? Am J Respir Crit Care Med. 2018;198(8):1000–11.PubMedCrossRef Kovacs G, Agusti A, Barbera JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H. Pulmonary vascular involvement in chronic obstructive pulmonary disease. Is there a pulmonary vascular phenotype? Am J Respir Crit Care Med. 2018;198(8):1000–11.PubMedCrossRef
36.
go back to reference Wang C, Xu J, Wu Z, Cheng M. Correlation between CT pulmonary vascular parameters and severity of patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Respir Med. 2019;39(7):515–20. Wang C, Xu J, Wu Z, Cheng M. Correlation between CT pulmonary vascular parameters and severity of patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Respir Med. 2019;39(7):515–20.
37.
go back to reference Huertas A, Guignabert C, Barbera JA, Bartsch P, Bhattacharya J, Bhattacharya S, Bonsignore MR, Dewachter L, Dinh-Xuan AT, Dorfmuller P, et al. Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy. Eur Respir J. 2018;51(4):10.CrossRef Huertas A, Guignabert C, Barbera JA, Bartsch P, Bhattacharya J, Bhattacharya S, Bonsignore MR, Dewachter L, Dinh-Xuan AT, Dorfmuller P, et al. Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy. Eur Respir J. 2018;51(4):10.CrossRef
38.
go back to reference Vaes AW, Spruit MA, Theunis J, Goswami N, Vanfleteren LE, Franssen FME, Wouters EFM, De Boever P. Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients. Acta Ophthalmol. 2018;96(6):539–49.PubMedCrossRef Vaes AW, Spruit MA, Theunis J, Goswami N, Vanfleteren LE, Franssen FME, Wouters EFM, De Boever P. Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients. Acta Ophthalmol. 2018;96(6):539–49.PubMedCrossRef
39.
40.
go back to reference Li L, Gao S, Fu Q, Liu R, Zhang Y, Dong X, Li Y, Li M, Zheng Y. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis. Clin Rheumatol. 2019;38(11):3169–78.PubMedCrossRef Li L, Gao S, Fu Q, Liu R, Zhang Y, Dong X, Li Y, Li M, Zheng Y. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis. Clin Rheumatol. 2019;38(11):3169–78.PubMedCrossRef
41.
go back to reference Kolodziej M, de Veer MJ, Cholewa M, Egan GF, Thompson BR. Lung function imaging methods in Cystic Fibrosis pulmonary disease. Respir Res. 2017;18(1):96.PubMedPubMedCentralCrossRef Kolodziej M, de Veer MJ, Cholewa M, Egan GF, Thompson BR. Lung function imaging methods in Cystic Fibrosis pulmonary disease. Respir Res. 2017;18(1):96.PubMedPubMedCentralCrossRef
42.
go back to reference Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, et al. Using transitional changes on high-resolution computed tomography to monitor the impact of cyclophosphamide or Mycophenolate mofetil on systemic sclerosis-related interstitial lung disease. Arthritis Rheumatol. 2020;72(2):316–25.PubMedCrossRef Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, et al. Using transitional changes on high-resolution computed tomography to monitor the impact of cyclophosphamide or Mycophenolate mofetil on systemic sclerosis-related interstitial lung disease. Arthritis Rheumatol. 2020;72(2):316–25.PubMedCrossRef
43.
go back to reference Distefano G, Fanzone L, Palermo M, Tiralongo F, Cosentino S, Ini C, Galioto F, Vancheri A, Torrisi SE, Mauro LA, et al. HRCT patterns of drug-induced interstitial lung diseases: a review. Diagnostics (Basel). 2020;10(4):244.CrossRef Distefano G, Fanzone L, Palermo M, Tiralongo F, Cosentino S, Ini C, Galioto F, Vancheri A, Torrisi SE, Mauro LA, et al. HRCT patterns of drug-induced interstitial lung diseases: a review. Diagnostics (Basel). 2020;10(4):244.CrossRef
44.
go back to reference Ferrazza AM, Gigante A, Gasperini ML, Ammendola RM, Paone G, Carbone I, Rosato E. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER. Clin Rheumatol. 2020;39(5):1537–42.PubMedCrossRef Ferrazza AM, Gigante A, Gasperini ML, Ammendola RM, Paone G, Carbone I, Rosato E. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER. Clin Rheumatol. 2020;39(5):1537–42.PubMedCrossRef
45.
go back to reference Gao L, Zhang J. Pulmonary high-resolution computed tomography (HRCT) findings of patients with early-stage coronavirus disease 2019 (COVID-19) in Hangzhou, China. Med Sci Monit. 2020;26:e923885.PubMedPubMedCentralCrossRef Gao L, Zhang J. Pulmonary high-resolution computed tomography (HRCT) findings of patients with early-stage coronavirus disease 2019 (COVID-19) in Hangzhou, China. Med Sci Monit. 2020;26:e923885.PubMedPubMedCentralCrossRef
46.
go back to reference Shao X, Niu R, Jiang Z, Shao X, Wang Y. Role of PET/CT in management of early lung adenocarcinoma. AJR Am J Roentgenol. 2020;214(2):437–45.PubMedCrossRef Shao X, Niu R, Jiang Z, Shao X, Wang Y. Role of PET/CT in management of early lung adenocarcinoma. AJR Am J Roentgenol. 2020;214(2):437–45.PubMedCrossRef
Metadata
Title
The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis
Authors
Tao Yang
Chihua Chen
Zhongyuanlong Chen
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-01374-6

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.